SARS-CoV-2 Gastrointestinal Infection Prolongs the Time to Recover From COVID-19

  title={SARS-CoV-2 Gastrointestinal Infection Prolongs the Time to Recover From COVID-19},
  author={Zhijie Xu and Meiwen Tang and Ping Chen and Hongyu Cai and Fei Xiao},
  journal={Frontiers in Medicine},
Objectives: We previously reported that SARS-CoV-2 infects the gastrointestinal (GI) epithelium. In this study, we aimed to explore the impact of SARS-CoV-2 GI infection on clinical outcomes of COVID-19. Materials and Methods: For this retrospective cohort study, 104 patients with COVID-19 were classified into a SARS-CoV-2 GI infection group and a non-infection group. The primary endpoint was the time of negative conversion of SARS-CoV-2 RNA in respiratory tract samples. The secondary outcome… 
1 Citations

Figures and Tables from this paper


Evidence for Gastrointestinal Infection of SARS-CoV-2
Evidence is provided for gastrointestinal infection of SARS-CoV-2, highlighting its potential fecal-oral transmission route and positive immunofluorescent staining of viral host receptor ACE2 and viral nucleocapsid protein in a case of Sars-Co V-2 infection.
Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection
GI tract may be a potential transmission route and target organ of SARS-CoV-2, potentially aggravated by various drugs including antibiotics.
Gastrointestinal and liver manifestations in patients with COVID-19
As the outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread over the world, the World Health Organization has
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study
  • L. Pan, M. Mu, L. Tu
  • Medicine
    The American journal of gastroenterology
  • 2020
It is found that digestive symptoms are common in patients with COVID-19 and that the index of suspicion may need to be raised earlier in at-risk patients presenting with digestive symptoms, but further large sample studies are needed to confirm these findings.
COVID-19 in gastroenterology: a clinical perspective
Interestingly, SARS-CoV2 RNA was detected in 50% of patients’ stool samples but was not clearly associated with abdominal symptoms, and in those with detectable faecal virus RNA, approximately half had diarrhoea and half had normal stool consistency.
Sex differences in immune responses that underlie COVID-19 disease outcomes
Examination of sex differences in viral loads, SARS-CoV-2-specific antibody titres, plasma cytokines and blood-cell phenotyping in patients with moderate COVID-19 found that a poor T cell response negatively correlated with patients’ age and was associated with worse disease outcome in male patients, but not in female patients.
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms
Attention to patients with COVID-19 with non-classic symptoms should increase to protect health providers, and sequence mutation of SARS-CoV-2 with m6A methylation and changed binding capacity with ACE2 was showed.
Clinical Characteristics of Coronavirus Disease 2019 in China
During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness, and patients often presented without fever, and many did not have abnormal radiologic findings.
Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus
It is suspected that ACE2-expressing small intestinal epithelium cells might be vulnerable to 2019-nCoV infection when people eat infected wild animals and diarrhea may serve as an indicator for infection, suggesting that clinicians should pay more attention to patients with diarrhea during the outbreak of pneumonia.